Cas No.: | 129580-63-8 |
Chemical Name: | Platinum, bis(acetato-κO)amminedichloro(cyclohexanamine)-, (OC-6-43)- (9CI) |
Synonyms: | BMS-182751;BMY-45594;JM-216 |
SMILES: | NC1CCCCC1.CC(O[Pt](Cl)(Cl)OC(C)=O)=O.N |
Formula: | C10H22Cl2N2O4Pt+2 |
M.Wt: | 500.2816 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Satraplatin (BMS-182751, BMY-45594, JM-216) is a platinum-based antineoplastic agent that binds to guanine residues in DNA, inhibits DNA replication and transcription, leads to subsequent apoptosis; shows similar cytotoxicity and pattern of cytotoxicity to cisplatin against human ovarian carcinoma cell lines (IC50=1.7 uM); shows antitumor selectivity far superior to cisplatin, carboplatin, or tetraplatin in vivo; orally active. Chemotherapeutic Agents Phase 2 Clinical |